{"organizations": [], "uuid": "5d04e3356d3c112c555741257f496b049ec5c484", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-crispr-therapeutics-commences-publ/brief-crispr-therapeutics-commences-public-offering-of-100-mln-common-shares-idUSASB0BZJ5", "country": "US", "domain_rank": 408, "title": "BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T13:30:00.000+02:00", "replies_count": 0, "uuid": "5d04e3356d3c112c555741257f496b049ec5c484"}, "author": "", "url": "https://www.reuters.com/article/brief-crispr-therapeutics-commences-publ/brief-crispr-therapeutics-commences-public-offering-of-100-mln-common-shares-idUSASB0BZJ5", "ord_in_thread": 0, "title": "BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff  jan", "sentiment": "none"}, {"name": "therapeutics ag", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 30 AM / Updated 23 minutes ago BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​ Reuters Staff \nJan 3 (Reuters) - Crispr Therapeutics Ag: \n* CRISPR THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES \n* CRISPR THERAPEUTICS AG - ‍COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF $100 MILLION OF ITS COMMON SHARES​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T13:30:00.000+02:00", "crawled": "2018-01-03T13:57:48.005+02:00", "highlightTitle": ""}